Table 4

Serum SAA Levels in Benign Disease, CIN, and CC Patients
Group Number Median
NNL 32 9.2
CIN 34 14.1
Stage I 33 22.7
Stage II 39 24.3
Adenocarcinoma 6 20.2
Squamous cell carcinoma 66 25.9
Pairwise Comparison P
NNL versus CIN 0.31
NNL versus stage I 0.002
CIN versus stage I 0.024
Stage I versus stage II 0.483
Adenocarcinoma and squamous cell carcinoma 0.626

NNL Indicates non-neoplastic lesion; CIN Indicates cervical intraepithelial neoplasias; CC Cervical carcinoma; SD, Standard deviation; P Values are from 2-sided Wilcoxon-Kruskal-Wallis tests for the indicated comparisons.

Ren et al.

Ren et al. Diagnostic Pathology 2014 9:16   doi:10.1186/1746-1596-9-16

Open Data